MedTrace Logo

Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes

NCT01288326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 254

Last updated 2017-01-26

No results posted yet for this study

Summary

The study is conducted in Europe. The aim of this observational study is to assess glycaemic control while using liraglutide under normal clinical practice conditions in Belgium.

Conditions

Interventions

DRUG

liraglutide

Liraglutide will be prescribed and titrated (individually adjusted) by the treating physician.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01288326 on ClinicalTrials.gov